• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.49% Nasdaq Up0.49%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    42.99 Up 0.64(1.51%) 2:09PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 19,769   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit 19,769   -   -   -  
    Operating Expenses
    Research Development16,575  15,498  12,194  10,161  
    Selling General and Administrative5,482  4,970  4,663  4,200  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (2,288) (20,468) (16,857) (14,361)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,096  1,024  982  980  
    Earnings Before Interest And Taxes(1,192)(19,444)(15,875)(13,381)
    Interest Expense -   -   -   -  
    Income Before Tax(1,192)(19,444)(15,875)(13,381)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(1,192)(19,444)(15,875)(13,381)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (1,192) (19,444) (15,875) (13,381)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (1,192) (19,444) (15,875) (13,381)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.